Carl Zeiss Meditec AG (LON:0DHC)

Market Cap	3.25B
Revenue (ttm)	1.87B
Net Income (ttm)	128.69M
Shares Out	n/a
EPS (ttm)	1.47
PE Ratio	25.28
Forward PE	21.58
Dividend	0.50 (1.21%)
Ex-Dividend Date	Mar 27, 2025

Volume	77,688
Average Volume	17,323
Open	41.12
Previous Close	41.40
Day's Range	40.52 - 41.34
52-Week Range	40.52 - 72.10
Beta	1.21
RSI	30.49
Earnings Date	Dec 11, 2025

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1846
• Employees: 5,730
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0DHC

Financial Performance

In 2024, Carl Zeiss Meditec AG's revenue was 2.07 billion, a decrease of -1.11% compared to the previous year's 2.09 billion. Earnings were 178.73 million, a decrease of -38.45%.

Financial numbers in EUR